ModelEdge
Cidara Therapeutics Inc.
CDTX
Filing type
10-K
Filing date
Mar 5, 2025
Updated
Mar 6, 2025 ยท 2:25 PM

Filing

10-KFY 2024

Exhibits

EX-4.5DESCRIPTION OF THE REGISTRANT'S SECURITIESEX-10.5NON-EMPLOYEE DIRECTOR COMPENSATION POLICY, AS AMENDEDEX-10.72020 INDUCEMENT INCENTIVE PLAN, AS AMENDEDEX-10.30EXECUTIVE OFFICERS EMPLOYMENT AGREEMENT, AS AMENDEDEX-19.1INSIDER TRADING POLICYEX-23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMEX-31.1CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934EX-31.2CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934EX-32.1CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002EX-32.2CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002GRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic